welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!

Effect of EPA and DHA in the Inflammation and Metabolic Disorders in DMD/DMB Patients

key information

study id #: NCT01826422

condition: Muscular Dystrophy, Duchenne

status: completed


The purpose of this study is to evaluate the effect of docosahexaenoic fatty acid and eicosapentaenoic fatty acid supplementation for six months on the inflammation state as well as the process of muscular regeneration and the metabolic disorders like obesity and insulin resistance in patients with Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (DMB) compared to those receiving placebo.

intervention: EPA and DHA, Placebo Comparator

mechanism of action: Omega-3 fatty acides to reduce inflammation

results: https://clinicaltrials.gov/ct2/show/results/NCT01826422

last updated: November 22, 2018